• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Introduction to 3-Chloro-4-ethoxybenzonitrile (CAS No. 916596-02-6)

3-Chloro-4-ethoxybenzonitrile (CAS No. 916596-02-6) is a versatile organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its unique structural properties and potential applications. This compound, characterized by a chloro substituent at the 3-position and an ethoxy group at the 4-position of a benzonitrile core, serves as a valuable intermediate in the synthesis of various bioactive molecules. Its molecular structure, featuring both electron-withdrawing and electron-donating groups, makes it particularly interesting for medicinal chemists seeking to develop novel therapeutic agents.

The benzonitrile moiety in 3-Chloro-4-ethoxybenzonitrile is known for its ability to participate in diverse chemical reactions, including nucleophilic substitution and condensation reactions, which are pivotal in drug discovery processes. The presence of the chloro group enhances the electrophilicity of the aromatic ring, facilitating further functionalization, while the ethoxy group introduces steric and electronic effects that can modulate the reactivity and biological activity of the compound. These features make it a preferred building block for constructing more complex molecules with tailored pharmacological properties.

In recent years, 3-Chloro-4-ethoxybenzonitrile has been extensively studied for its role in developing small-molecule inhibitors targeting various biological pathways. One notable area of research involves its application in the synthesis of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The benzonitrile core is often incorporated into kinase inhibitors due to its ability to form hydrogen bonds with key residues in the active site of the enzyme, improving binding affinity and selectivity. For instance, derivatives of 3-Chloro-4-ethoxybenzonitrile have shown promise in inhibiting Janus kinases (JAKs), which play a critical role in immune responses and have been implicated in autoimmune disorders.

Another emerging application of 3-Chloro-4-ethoxybenzonitrile is in the development of antimicrobial agents. The increasing prevalence of drug-resistant bacteria has driven research into novel antimicrobial compounds derived from natural product scaffolds. The structural motif of 3-Chloro-4-ethoxybenzonitrile resembles several bioactive natural products, such as flavonoids and benzophenones, which exhibit potent antimicrobial activities. Researchers have modified this compound by introducing additional functional groups or coupling it with other heterocycles to enhance its antimicrobial efficacy against Gram-positive and Gram-negative bacteria. Preliminary studies indicate that certain derivatives exhibit significant activity against methicillin-resistant Staphylococcus aureus (MRSA) and other multidrug-resistant pathogens.

The agrochemical industry has also recognized the potential of 3-Chloro-4-ethoxybenzonitrile as a precursor for developing novel pesticides and herbicides. The compound’s ability to undergo further chemical transformations allows for the creation of molecules with specific modes of action against pests and weeds. For example, researchers have synthesized derivatives of 3-Chloro-4-ethoxybenzonitrile that act as inhibitors of essential plant enzymes, leading to selective weed control without harming crops. These findings highlight the compound’s versatility and its importance in sustainable agriculture practices.

From a synthetic chemistry perspective, 3-Chloro-4-ethoxybenzonitrile is valued for its role in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are fundamental in constructing biaryl structures found in many pharmaceuticals. The chloro substituent at the 3-position can be readily transformed into other functional groups via palladium-catalyzed reactions, enabling access to a wide range of derivatives with diverse biological activities. Similarly, the ethoxy group can be modified through oxidation or deprotection strategies to introduce additional pharmacophores.

The pharmaceutical industry’s interest in 3-Chloro-4-ethoxybenzonitrile extends beyond kinase inhibitors and antimicrobial agents. It has been explored as a precursor for developing central nervous system (CNS) drugs due to its ability to cross the blood-brain barrier when appropriately functionalized. Researchers have investigated its derivatives as potential monoamine oxidase (MAO) inhibitors, which are used to treat neurodegenerative diseases such as Parkinson’s disease and depression. The structural features of 3-Chloro-4-ethoxybenzonitrile, including its aromaticity and electron-deficient nature, contribute to its suitability for designing CNS-active compounds.

In conclusion, 3-Chloro-4-ethoxybenzonitrile (CAS No. 916596-02-6) is a multifaceted compound with significant implications across pharmaceuticals, agrochemicals, and synthetic chemistry. Its unique structural features make it an invaluable intermediate for developing novel bioactive molecules targeting various diseases, including cancers, infectious diseases, and neurodegenerative disorders. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is likely to grow further.

• 796067-63-5(3-chloro-5-ethoxy-4-hydroxyBenzonitrile)
• 749920-57-8(3-Chloro-4-ethoxy-5-methoxy-benzonitrile)
• 1426847-38-2(3-Chloro-4-(2,3-dihydroxypropoxy)benzonitrile)
• 142247-74-3(4-(Benzyloxy)-3-chlorobenzonitrile)
• 933585-28-5(4-Chloro-3-ethoxybenzonitrile)
• 491581-06-7(3-Chloro-4,5-diethoxy-benzonitrile)
• 102151-33-7(3-Chloro-4-methoxybenzonitrile)
• 3336-38-7(3,5-Dichloro-4-methoxybenzonitrile)
• 189628-40-8(4-Chloro-3-methoxybenzonitrile)
• 853953-30-7(4-BENZYLOXY-3-CHLORO-BENZONITRILE)